Anyone who hates taking a pill a day, or has trouble remembering doing so, take heed. Pharmaceutical company GSK has announced the development of a new anti-HIV drug for prep which only requires one injected dose every two months.
PinkNews reports that GSK claims to have stopped early testing of the drug after it proved 69% more effective at preventing the transmission of HIV than oral PrEP.